The British patient advocates the antitrust regulator to probe drug manufacturers
The UK antitrust regulator was invited by patient defense groups to investigate several major drug manufacturers and their British lobbying organization for “suspects” and “coordinated” efforts to increase the prices of medicines. The backdrop of the complaint was an ongoing row between the pharmaceutical industry and the British government for the compulsory discounts that pharmaceutical […]